Alicia Beeghly-Fadiel

SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine.

Gil Alterovitz, Kenneth D Mandl, Jeremy L Warner, 2018, JCO precision oncology.

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.

Wei Zheng, Ben Zhang, Jirong Long, 2011, The Lancet. Oncology.

A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.

Jennifer A. Doherty, Peter A. Fasching, Susan J. Ramus, 2018 .

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.

Harvey Risch, Yian A Chen, Mads Thomassen, 2018, Cancer research.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study.

Wei Lu, Wei Zheng, Ying Zheng, 2013, American journal of epidemiology.

Replication study for reported SNP associations with breast cancer survival

Wei Lu, Wei Zheng, Ying Zheng, 2012, Journal of Cancer Research and Clinical Oncology.

Abstract 5114: Deep phenotype extraction to facilitate cancer research: Extending DeepPhe to ovarian cancer

Harry Hochheiser, Jeremy L. Warner, Sean Finan, 2019, Bioinformatics, Convergence Science, and Systems Biology.